Figuring out autoantigens of serological autoantibodies requires costly strategies, reminiscent of protein microarrays or IP+MS. Thus, sera are generally pre-screened for attention-grabbing immunopatterns by way of immunocytochemistry/immunohistochemistry. Nonetheless, distinguishing immunopatterns